3rd gen glp 1 GLP-1-Based Therapeutics Summit 2026 [04/14/26] The GLP-1 Drugs Revolution: How

Rotating injection sites prevents lipohypertrophy, a condition where repeated injections in the same spot cause fatty tissue buildup

Curr Gastroenterol Rep 12:319330

Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder

Potential applications in age-related muscle loss (sarcopenia) or disease-related muscle wasting remain speculative pending investigation of BPC-157's effects on muscle mass maintenance and protein synthesis in chronic conditions

AstraZeneca discontinued these three formulations in the US in recent years, but generic Byetta was approved by the FDA in late 2024